CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). [electronic resource]
- Transplantation Mar 2013
- 828-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1534-6080
10.1097/TP.0b013e31827eef57 doi
ATP Binding Cassette Transporter, Subfamily B ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics Adult Area Under Curve Cytochrome P-450 CYP3A--genetics Dose-Response Relationship, Drug Genotype Haplotypes Humans Immunosuppressive Agents--pharmacokinetics Kidney Transplantation--methods Middle Aged Monocytes--drug effects Polymorphism, Genetic T-Lymphocytes--drug effects Tacrolimus--pharmacokinetics Treatment Outcome